FTSE All-Share
|
5 634,04
|
-10,77
|
-0,19 %
|
Analysen zu FTSE All-Share-Werten
| 23.10.25 | Unilever Outperform | Bernstein Research | |
| 23.10.25 | Unilever Underperform | RBC Capital Markets | |
| 23.10.25 | Unilever Overweight | JP Morgan Chase & Co. | |
| 23.10.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 22.10.25 | GSK Neutral | UBS AG | |
| 22.10.25 | GSK Hold | Deutsche Bank AG | |
| 22.10.25 | AstraZeneca Sell | Deutsche Bank AG | |
| 22.10.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.10.25 | Diageo Outperform | Bernstein Research | |
| 21.10.25 | HSBC Holdings Overweight | Barclays Capital | |
| 20.10.25 | Diageo Outperform | Bernstein Research | |
| 20.10.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 20.10.25 | Diageo Overweight | Barclays Capital | |
| 20.10.25 | Vodafone Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.10.25 | Diageo Hold | Deutsche Bank AG | |
| 17.10.25 | HSBC Holdings Neutral | JP Morgan Chase & Co. | |
| 17.10.25 | Diageo Buy | UBS AG | |
| 16.10.25 | Diageo Buy | Jefferies & Company Inc. | |
| 16.10.25 | BP Hold | Jefferies & Company Inc. | |
| 16.10.25 | Diageo Neutral | JP Morgan Chase & Co. | |
| 16.10.25 | AstraZeneca Sell | Deutsche Bank AG | |
| 15.10.25 | Rio Tinto Hold | Deutsche Bank AG | |
| 15.10.25 | Rio Tinto Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.10.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 14.10.25 | BP Sector Perform | RBC Capital Markets | |
| 14.10.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 14.10.25 | Rio Tinto Kaufen | DZ BANK | |
| 14.10.25 | Rio Tinto Neutral | UBS AG | |
| 14.10.25 | BP Neutral | UBS AG | |
| 14.10.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 14.10.25 | Vodafone Group Buy | Deutsche Bank AG | |
| 14.10.25 | BP Hold | Jefferies & Company Inc. | |
| 14.10.25 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 14.10.25 | Rio Tinto Hold | Jefferies & Company Inc. | |
| 13.10.25 | London Stock Exchange Outperform | RBC Capital Markets | |
| 13.10.25 | AstraZeneca Buy | UBS AG | |
| 13.10.25 | HSBC Holdings Neutral | UBS AG | |
| 13.10.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 10.10.25 | London Stock Exchange Overweight | JP Morgan Chase & Co. | |
| 10.10.25 | Unilever Overweight | JP Morgan Chase & Co. |
HOT STOCKS DER LETZTEN 3 TAGE
| Rio Tinto | 4 |
| Shell | 4 |
| AstraZeneca | 3 |
| GSK | 2 |
| Unilever | 2 |
| Diageo | 1 |
| London Stock Exchange | 1 |
| Vodafone Group | 1 |
| BP | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.